Spotlight
Commentary
Cultural Corner
Psychiatric Practice
Series
News
Job Board
CME/CE
Partners
Editorial
Subscribe
Francine Goodman, PharmD
Articles
Marketing Off-Label Uses: Shady Practices Within a Gray Market
Cathy L. Melvin, PhD, MPH;Timothy S. Carey, MD, MPH;John M. Oldham, MD;John W. Williams Jr, MD;Francine Goodman, PharmD;Thomas R. Linden, MD;W. Douglas Evans, PhD;Gary L. Kreps, PhD;Leah M. Ranney, PhD
August 7th 2009For pharmaceutical companies, off-label use of a drug represents a substantial “gray market,” to which the company is unable to sell their product directly, yet may be a significant revenue stream. Some drugs have been used more for off-label purposes than for originally approved indications.1
Latest Updated Articles
Published: September 14th 2020 | Updated: December 26th 2024
Mini Quiz: A New Dawn in Suicide Prevention
Published: March 19th 2021 | Updated: December 26th 2024
Mini Quiz: Treatment for Pedophilia?
Published: March 23rd 2021 | Updated: December 26th 2024
Poor DSM-5—So Misunderstood!
Published: January 21st 2016 | Updated: December 26th 2024
Mini Quiz: Methods of Suicide
Published: December 20th 2024 | Updated: December 26th 2024
Poll: How Are You Handling the Holidays as a Clinician?
Published: August 3rd 2015 | Updated: December 26th 2024
Mini Quiz: DSM-5 Basics
